Recent advances in motor neuron disease.

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
• Riluzole is the only approved treatment, highlighting a need for new therapeutic strategies.
• The etiology of ALS is complex and multifactorial.

Purpose of the Study:

• To review recent advancements in understanding the molecular basis of sporadic and familial ALS.
• To discuss improvements in the clinical management and treatment of ALS patients.

Main Methods:

• Review of recent scientific literature on ALS genetics and molecular pathology.
• Analysis of current treatment approaches and their impact on patient outcomes.

Main Results:

• Mutations in TDP-43 and FUS genes are implicated in familial ALS.
• TDP-43 pathology is observed in sporadic ALS, suggesting a role for altered RNA processing.
• Improvements in patient survival are linked to multidisciplinary care, ventilation, and feeding support.

Conclusions:

• Genetic and pathological insights are advancing the understanding of ALS.
• Novel therapeutic strategies are anticipated based on new research findings.
• Multidisciplinary care demonstrably enhances survival and quality of life for individuals with ALS.